Veracyte
VCYT
370 hedge funds and large institutions have $5.23B invested in Veracyte in 2026 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 128 increasing their positions, 123 reducing their positions, and 41 closing their positions.
444% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $2.34M
93% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 41
84% more capital invested
Capital invested by funds: $2.84B → $5.23B (+$2.39B)
11% more funds holding
Funds holding: 334 → 370 (+36)
1.03% more ownership
Funds ownership: 111.11% → 112.14% (+1%)
4% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 123
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$43.9M |
| 2 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$26.8M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$18.5M |
| 4 |
Morgan Stanley
New York
|
+$16.5M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$39.1M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$31.8M |
| 3 |
DM
Deerfield Management
New York
|
-$26.2M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$14.5M |
VCYT Hedge Fund Activity: Q2 2026 in Review
370 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2026, worth a combined $5.23B — up 84% from $2.84B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new VCYT positions and 41 closed out — a net gain of 38 holders — while 128 added to existing stakes and 123 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $43.9M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $39.1M.
- 370 institutional investors held Veracyte (VCYT) as of Q2 2026, up from 334 in Q1 2026.
- Funds reported $5.23B of Veracyte stock for Q2 2026, up 84% quarter-over-quarter.
- 79 funds opened new Veracyte positions in Q2 2026 and 41 closed out, a net change of +38 holders.
- The largest Veracyte buyer in Q2 2026 was Driehaus Capital Management, an estimated $43.9M added.
- The largest Veracyte seller in Q2 2026 was ArrowMark Colorado Holdings, an estimated $39.1M sold.
Based on aggregated 13F filings for Q2 2026.